EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Kinase-Targeted Therapies for Glioblastoma

Maria Salbini, Alessia Formato, Maria Patrizia Mongiardi iD, Andrea Levi, Maria Laura Falchetti iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26083737 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Maria Salbini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry and Cell Biology, National Research Council, Via Ercole Ramarini 32, Monterotondo, 00015 Rome, Italy. Hauptthemen laut MEDLINE: Glioblastoma, Protein Kinase Inhibitors, Brain Neoplasms, Molecular Targeted Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, AIRC IG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein phosphorylation and dephosphorylation are key mechanisms that regulate cellular activities. The addition or removal of phosphate groups by specific enzymes, known as kinases and phosphatases, activates or inhibits many enzymes and receptors involved in various cell signaling pathways. Dysregulated activity of these enzymes is associated with various diseases, predominantly cancers. Synthetic and natural single- and multiple-kinase inhibitors are currently being used as targeted therapies for different tumors, including glioblastoma. Glioblastoma IDH-wild-type is the most aggressive brain tumor in adults, with a median overall survival of 15 months. The great majority of glioblastoma patients present mutations in receptor tyrosine kinase (RTK) signaling pathways responsible for tumor initiation and/or progression. Despite this, the multi-kinase inhibitor regorafenib has only recently been approved for glioblastoma patients in some countries. In this review, we analyze the history of kinase inhibitor drugs in glioblastoma therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaProtein Kinase InhibitorsBrain NeoplasmsMolecular Targeted TherapyAntineoplastic AgentsHumansSignal TransductionAnimals

Stichwörter der Autor:innen

glioblastomakinase inhibitortherapy

Substanzen

Protein Kinase InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Institute of Biochemistry and Cell Biology, National Research Council, Via Ercole Ramarini 32, Monterotondo, 00015 Rome, Italy.

ORCID-Profile: Maria Patrizia Mongiardi, Maria Laura Falchetti

Förderung

  • Italian Association for Cancer Research
  • AIRC IG

Zitieren

APA

Salbini, M., Formato, A., Mongiardi, M. P., Levi, A., & Falchetti, M. L. (2025). Kinase-Targeted Therapies for Glioblastoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083737

Vancouver

Salbini M, Formato A, Mongiardi MP, Levi A, Falchetti ML. Kinase-Targeted Therapies for Glioblastoma. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083737

BibTeX
@article{Salbini2025,
  author = {Salbini, Maria and Formato, Alessia and Mongiardi, Maria Patrizia and Levi, Andrea and Falchetti, Maria Laura},
  title = {Kinase-Targeted Therapies for Glioblastoma},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26083737}
}
Kostenlos starten →